Physician profile
Robert W Pollack
NPI 1588816771
$18,737.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $238 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17,552.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $234.65 | 2019 | |
| Allergan, INC. | $233.25 | 2019-2020 | |
| Neuronetics, INC. | $144.95 | 2019 | |
| Neurocrine Biosciences, INC. | $139.72 | 2019-2020 | |
| Medtronic, INC. | $134.94 | 2024 | Intellis Adaptivestim |
| Ironshore Pharmaceuticals INC. | $94.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.40 | 2019 | |
| Avanir Pharmaceuticals, INC. | $41.99 | 2019 | |
| Merck Sharp & Dohme LLC | $27.04 | 2019 | |
| Sunovion Pharmaceuticals INC. | $21.40 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.68 | 2020 | |
| Shire North American Group INC | $16.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.